Скачать или смотреть Decoding Cancer Research: New Hope for Childhood Brain Cancer Treatment

At Learn to Beat Cancer, we stay up to date on the latest cancer research so you don’t have to. In this episode, we explore a groundbreaking discovery from Emory University and international collaborators that could transform how we treat childhood brain cancer.

Researchers have developed a novel drug called CT179, which specifically targets cancer stem cells—the main culprits behind tumor recurrence and therapy resistance. By inhibiting a protein called OIG2, CT179 blocks tumor growth and prevents recurrence in preclinical models. Remarkably, this drug crosses the blood-brain barrier, a major challenge for brain cancer treatments, and enhances the effectiveness of radiation therapy.

Focused on medulloblastoma, the most common childhood brain cancer, this research also holds promise for other aggressive brain cancers like glioblastoma. Using advanced tools like CRISPR and single-cell RNA sequencing, scientists confirmed that targeting tumor-initiating cells represents a paradigm shift in cancer treatment. The next step is clinical trials, offering hope for improved survival rates and quality of life for children with brain cancer.

Learn more about this groundbreaking research and how it could revolutionize cancer treatment by visiting our website: https://www.learntobeatcancer.org

Watch more episodes of Decoding Cancer Research here: https://www.learntobeatcancer.org/dec...

Read the related research article here: https://news.emory.edu/stories/2025/0...